Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Acute Liver Failure | Kisho | Kisho

Back to Acute Liver Failure

Acute Liver Failure — NIH Grants & Funding

Active and recent NIH-funded research on Acute Liver Failure. Data from NIH RePORTER, last 36 months.

MONDO:0019542

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Acute Liver Failure has active NIH research funding with 17 funded grants totaling $31.6M.

17funded grants from NIH

Portfolio: $9.4MCumulative: $31.6M8 active9 completed19 PIs12 institutions

2 new grants started in the last 12 months.

By Research Theme

Basic Science

Translational

Clinical

Biomarker / Dx

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$8.8M

FY22

$5.5M

FY23

$9.4M

FY24

$6.1M

FY25

$1.8M

FY26

By Funding Mechanism

R01

F31

K08

R21

R42

R44

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Acute Liver Failure. Strongest funded area: Basic Science. Largest gap: Clinical Research.

Clinical ResearchFunded, Few Publications

3 funded grants in Clinical Research but only 1 related publication found for acute liver failure. This may indicate early-stage research that hasn't yet produced published results.

Translational / Drug DevelopmentFunded, Few Publications

3 funded grants in Translational / Drug Development but only 2 related publications found for acute liver failure. This may indicate early-stage research that hasn't yet produced published results.

Adjacent Research(13 grants)

These grants mention Acute Liver Failure as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(13)

OtherR44Active

Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers

Baicu, Simona et al.·SYLVATICA BIOTECH, INC.·NORTH CHARLESTON, SC

$980,782 (FY2025)

NIH RePORTER

OtherR01Active

Novel strategies to accelerate repair of drug-induced hepatotoxicity

Luyendyk, James·MICHIGAN STATE UNIVERSITY·EAST LANSING, MI

$559,602 (FY2025)

NIH RePORTER

OtherR01Active

Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity

Copple, Bryan et al.·MICHIGAN STATE UNIVERSITY·EAST LANSING, MI

$487,951 (FY2026)

NIH RePORTER

OtherR15Completed

Generative-AI based system for accurate prediction of deceased donor liver-transplant (DDLT) outcome and viability

El-baz, Ayman·UNIVERSITY OF LOUISVILLE·LOUISVILLE, KY

$464,073 (FY2023)

NIH RePORTER

OtherR01Active

HSPG Interactions in Liver Disease

Park, Pyong Woo·BOSTON CHILDREN'S HOSPITAL·BOSTON, MA

$451,079 (FY2025)

NIH RePORTER

OtherR21Completed

A Novel Human Virus in Patients with Cryptogenic Liver Disease

FAN, XIAOFENG·SAINT LOUIS UNIVERSITY·SAINT LOUIS, MO

$189,375 (FY2024)

NIH RePORTER

OtherSB1Completed

AcetaSTAT Validation and Commercialization

James, Laura·ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC·LITTLE ROCK, AR

$1,067,121 (FY2025)

NIH RePORTER

OtherR01Completed

A chicken model to study hepatitis E virus pathogenesis

MENG, XIANG-JIN·VIRGINIA POLYTECHNIC INST AND ST UNIV·BLACKSBURG, VA

$400,000 (FY2023)

NIH RePORTER

OtherR21Completed

Biofabrication of Multicompartment Human Liver Tissues for Chemical Screening

Khetani, Salman et al.·UNIVERSITY OF ILLINOIS AT CHICAGO·Chicago, IL

$194,533 (FY2022)

NIH RePORTER

OtherR21Completed

Evaluating hepatitis E virus ribavirin resistance clinical outcomes in the immunosuppressed pig model

Jung, Kwonil et al.·OHIO STATE UNIVERSITY·Columbus, OH

$185,219 (FY2022)

NIH RePORTER

Kisho

Acute Liver Failure — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(13 grants)

Other(13)

Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers

Novel strategies to accelerate repair of drug-induced hepatotoxicity

Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity

Generative-AI based system for accurate prediction of deceased donor liver-transplant (DDLT) outcome and viability

HSPG Interactions in Liver Disease

A Novel Human Virus in Patients with Cryptogenic Liver Disease

AcetaSTAT Validation and Commercialization

A chicken model to study hepatitis E virus pathogenesis

Biofabrication of Multicompartment Human Liver Tissues for Chemical Screening

Evaluating hepatitis E virus ribavirin resistance clinical outcomes in the immunosuppressed pig model

Top Funded Institutions

Top Principal Investigators